Co-founder and CEO of Chardon Pharma is Ard Peeters. He is also connected to the Radboud University in Nijmegen as professor in Behavioural pharmacology. Ard combined his academic career with  that in the pharmaceutical industry (Organon, Schering Plough, Merck).

CEO

Co-founder and director of Chardon Pharma: Ard Peeters

Our Companies

E-Assyst B.V.

E-Assyst B.V. is a spin-off company of Chardon Pharma. It’s goal is to develop an e-health solution to support the treatment of (gambling) addiction.

E-Assyst B.V. was founded 12 January 2015.

CEO: Jorrit van den Breemer (We-Boost BV)
CSO: Ard Peeters (Chardon Pharma)


Digest-Inn B.V.

Digest-Inn B.V. is a spin-off company of Chardon Pharma. It’s goal is to develop an applied game for the treatment of obesity.

Digest-Inn B.V. was founded 16 January 2016.

CEO: Teun Aalbers (GainPlay Studio)
CSO: Ard Peeters (Chardon Pharma)


Orexa B.V.

Orexa B.V. is a spin-off company of Chardon Pharma. It’s goal is to develop products to prevent and treat malnutrition.
Orexa B.V. was founded 24 November 2016.

CEO (acting): Ard Peeters (Chardon Pharma)
CSO: Ard Peeters (Chardon Pharma)


Hairstressor B.V.

Hairstressor B.V. is a spin-off company of Chardon Pharma. It is a service company that analyses stress hormone levels in hair from animals and humans.
Hairstressor B.V. was founded 28 March 2017.

CEO: Wieke de Bruin
CSO: Ard Peeters (Chardon Pharma)



The Chardon Group